Akira Endo1, Fumio Nagatani, Chikuma Hamada
1Biomedical Data Sciences Department, GlaxoSmithKline K.K., Tokyo, Japan. akira.2.endo@gsk.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study introduces a novel method for balancing prognostic variables in clinical trials using Kullback-Leibler divergence (KLD). The approach improves upon existing methods by ensuring more stable and precise parameter estimates.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: